Although options have a reputation of being risky, they can be used to reduce the risk of your stock holdings. Read More

Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Analyst Articles
Coming back strong after Covid Read More
2 of our picks are in the thick of it Read More
Breakthroughs in biological drugs have enabled physicians to treat many diseases that have been resistant to conventional therapies. Read More
This week we check in on the two specialty metals producers in our Eastern Fireworks Portfolio, Materion (NYSE: MTRN) and AMG Advanced Metallurgical Group (OTCMKTS: AMVMF). Both stocks have performed well since we recommended them, up approximately 60% and 80%, respectively, as both rode strong demand tailwinds. Materion has just… Read More
The FDA approved Biogen's Alzheimer's drug. That's great news for Biogen and its shareholders, but it's also fantastic news for a competitor. Read More
As the saying goes, the squeaky wheel gets the grease. Stocks in our portfolios that don’t require our constant attention are usually doing well. That’s certainly the case with Growth Portfolio’s IQVIA Holdings (NYSE: IQV). Since joining Growth Portfolio in May 2018, the stock has quietly delivered a 160% return… Read More
Its own Alzheimer’s drug will benefit Read More
Benefiting from its importance to Taiwan Read More
Some investors are scared off by the K-1 and UBTI when it comes to MLPs. Let's shed some light on those two factors. Read More